<qa>  What is the study hypothesis that exenatide can reduce subclinical atherosclerosisThe research hypothesis is to assess whether exenatide once weekly can reduce subclinical atherosclerosis as measured by carotid-intima media thickness cIMT in patients with T2DM. 